Considering that higher than 70% of ovarian cancer are high grade serous subtype with high p53 mutation rate (> 90%), it is likely that suppression of p53 and subsequent defect of mitochondrial fragmentation were observed in most cases of ovarian cancer, associated with chemoresistance. The gene discussed is TP53; the disease is ovarian cancer.